By limiting iron availability, LF also affects tumor metabolism—it reduces ferritin and transferrin receptor 1 (TfR1) expression, which limits iron uptake by cancer cells, while increasing ferroportin levels, facilitating the removal of iron from cells. This evidence concerns the gene SLC40A1 and neoplasm.